Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Ophthalmol ; 17(7): 1248-1254, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39026914

RESUMO

AIM: To report a one-year clinical outcomes of low-dose laser cycloplasty (LCP) among malignant glaucoma patients. METHODS: In this prospective, multicenter, non-comparative clinical study, participants with malignant glaucoma were recruited and underwent LCP at eight ophthalmic centers in China. Patients were followed up at 1wk, 1, 3, 6, and 12mo. Intraocular pressure (IOP), number of glaucoma medications, anterior chamber depth (ACD), and complications were recorded. Anatomical success was defined as the reformation of the anterior chamber based on slit-lamp biomicroscopy. Recurrence was defined by the presence of a shallow or flat anterior chamber after initial recovery from treatment. RESULTS: A total of 34 eyes received LCP. Mean IOP and medications decreased from 36.1±11.5 mm Hg with 3.3±1.5 glaucoma medications pre-treatment to 20.9±9.8 mm Hg (P<0.001) with 2.9±1.6 medications (P=0.046) at 1d, and 17.4±6.7 mm Hg (P<0.001) with 1.3±1.7 medications (P<0.001) at 12mo. The ACD increased from 1.1±0.8 mm at baseline to 1.7±1.0 mm and to 2.0±0.5 mm at 1d and 12mo, respectively. A total of 32 (94.1%) eyes achieved initial anatomical success. During follow-up, 2 (5.9%) eyes failed and 8 (23.5%) eyes relapsed, yielding a 12-month anatomical success rate of 64.3%. Complications including anterior synechia (8.82%), choroidal/ciliary detachment (5.88%) and hypopyon (2.94%) were observed within 1wk. CONCLUSION: LCP is simple, safe, and effective in reforming the anterior chamber in malignant glaucoma.

3.
Zhonghua Yan Ke Za Zhi ; 42(3): 212-7, 2006 Mar.
Artigo em Chinês | MEDLINE | ID: mdl-16643751

RESUMO

OBJECTIVE: To observe anti-proliferative effect of herpes simplex virus thymidine kinase gene system (HSV-tk) on human Tenon capsule fibroblasts (HTFs) and it's mechanism. METHODS: Retroviral vector was constructed containing HSV-tk gene and transfer to packaging cell line PT67. The positive clones was selected with G418 and the supernatant was collected which contains virus particles. The titer of the virus was also calculated. The virus particles were verified by transmission electron microscope (TEM). PCR was carried out to detect the integrity of tk gene into viral DNA genome. HTFs cells were infected with the virus and the positive clones were selected for propagation culture. RT-PCR and Western blot were used to detect tk gene expression. The anti-proliferative effect of tk gene on HTFs cells was determined by MTT. Apoptosis of cells was detected by Hoechst 33258 DNA staining and flow cytometry. The morphologic changes of the cell were observed by TEM. RESULTS: The retroviral vector pL (tk) SN was constructed successfully which was verified by enzyme cutting. The shape of virus particles derived from the package cells appeared to be oval or spherical under TEM with the diameter around 100 nm. The tk gene was detected in the viral DNA genome by PCR. The virus titer was 4 x 10(7) cfu/ml. The expression of tk gene was detected by RT-PCR and Western blot both in mRNA and protein level. The anti-proliferative effect of tk gene on HTFs cells was dose-dependent, all cells were died 5 days after 5 x 10(-3) g/L GCV being added, IC50 = 6 x 10(-4) g/L. Both necrosis and apoptosis were observed in this study and the apoptosis rate was increased with increasing dose of GCV. CONCLUSIONS: The proliferation of HTFs cells in vitro could be effectively inhibited by the killing effect of HSV-tk-GCV system through the pathway of necrosis and apoptosis.


Assuntos
Antivirais/farmacologia , Fibroblastos/patologia , Ganciclovir/farmacologia , Simplexvirus/genética , Timidina Quinase/genética , Apoptose/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Túnica Conjuntiva/efeitos dos fármacos , Tecido Conjuntivo/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Vetores Genéticos/genética , Humanos , Simplexvirus/enzimologia , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...